Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024 08:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
March 13, 2024 16:05 ET
|
Anika Therapeutics Inc.
Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on March 1,...
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
February 13, 2024 09:00 ET
|
Anika Therapeutics Inc.
Announcing the limited market release of X-Twist™ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue repair at AAOS Focusing on its full Regenerative, Sports...
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 28, 2023 09:00 ET
|
Anika Therapeutics Inc.
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD,...
Anika to Participate in Upcoming Investor Conferences
November 07, 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
November 02, 2023 16:05 ET
|
Anika Therapeutics Inc.
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively ...
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 10, 2023 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...